<DOC>
	<DOCNO>NCT01979406</DOCNO>
	<brief_summary>The purpose study evaluate 2 vaccine candidate anthrax compare positive ( vaccine ) control study normal healthy volunteer .</brief_summary>
	<brief_title>A Phase 1 Ascending Dose Study Assess Safety Immunogenicity Adenovirus Anthrax Vector Candidate Vaccines</brief_title>
	<detailed_description>A Phase 1 , randomize , double-blind , positive control , increase dose clinical trial healthy adult subject multiple site . The study assess safety immunogenicity two adenovirus vaccine candidate anthrax compare positive control , Anthrax Vaccine Adsorbed ( AVA ) . The trial enroll 108 subject anthrax vector vaccine arm 12 subject AVA positive control subject . The study look three different dose oral dosage Ad4-PA ( protective antigen ) Ad4-PA-GPI ( 10^9 , 10^10 , 10^11 vp/dose ) well 3 vaccine administration schedule ( 1 15 day ; 1 29 day ; 1 , 15 , 29 day ) ; 2 3 schedule include intramuscular ( IM ) AVA booster immunization , 1 schedule include 3 vaccine administration Ad4-PA Ad4-PA-GPI ( glycosylphosphatidylinositol ) alone , 1 schedule include 3 vaccine administration AVA alone .</detailed_description>
	<mesh_term>Anthrax</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Able understand study give write informed consent . Healthy men woman age 1840 year old , BMI 18 36 kg/m2 Women child bear potential must negative serum pregnancy test screen negative urine pregnancy test prior vaccination vaccination day ; must also willing use adequate birth control duration study additional pregnancy test indicate . Intact upper arm sufficient muscular tissue deltoid region IM vaccine administration . Subject must available study duration Subject must avoid strenuous exercise least 72 hour prior study vaccine administration . Subject healthcare worker direct contact patient household contact ( HHC ) immunodeficient HIVpositive , pregnant , unstable medical condition , age 18 . Subject childcare worker parent direct contact child 5 year old young . Subject directly prepare food food industry . Pregnant breastfeed throughout duration study final visit Military service 1971 1999 , 2012 Ad4 vaccine was/is routinely give Employment industry involve contact ruminant animal , veterinary science , potential exposure B. anthracis Received previous Ad4 vaccination experimental Ad4 vector vaccine Received previous anthrax vaccine Received plan receive approve investigational vaccine 30 day prior first study vaccination 30 day final study vaccination live attenuate vaccine 15 day prior first study vaccination 15 day final study vaccination inactivate vaccine HIV Hepatitis B C positive Immunodeficient unstable medical condition include psychiatric condition Active past history acute chronic gastrointestinal condition Active past history cancer except basal cell carcinoma Recipient bone marrow solid organ transplant Received plan receive systemic antiviral medication , within 30 day prior first study vaccination Known allergy component study vaccine Known allergy , know medical condition precludes use systemic antiviral medication Received plan receive medication indicate decrease acidity stomach include : Proton pump inhibitor antacids histamine 2receptor antagonist Received plan receive immunoglobulin blood product within 60 day prior first study vaccination Received plan receive investigational drug within 30 day prior first study vaccination Received plan receive systemic immunosuppressive therapy , radiation therapy , inhaled steroid within 30 day prior first study vaccination Asthmatic require asthmatic medication daily basis Use systemic chemotherapy within 5 year prior study Body temperature &gt; 38.1°C acute illness within 3 day prior vaccination History excessive alcohol consumption , drug abuse , significant psychiatric illness History GuillainBarré Syndrome Blood donation within 2 month prior first study vaccination Expected noncompliant study visit plan move away live different HHCs next 8 month Drinks 1200 mL tea/coffee/cocoa/cola caffeinated beverage per day . Any condition find view primary investigator would impede full study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Anthrax vaccine</keyword>
</DOC>